Investor Relations

Complete overview of the company's information

Information for shareholders


Share Capital and Dividends
Year N. of Shares Nominal Value Share Capital Dividend Unit Monte Dividendi Exchange
2022 18.978.097 € 1,00 € 18.978.097,00 N.A. N.A. Mercato Euronext Growth Milan
2021 18.978.097 € 1,00 € 18.978.097,00 N.A. N.A. Mercato Euronext Growth Milan
2020 18.978.097 € 1,00 € 18.978.097,00 N.A. N.A. Mercato AIM
2019 14.324.956 € 1,00 € 14.324.956,00 An ordinary share for every 100 shares and € 0.025 for each ordinary share € 354.552 e n. 141.820 ordinary shares Mercato AIM
2018 14.324.956 € 1,00 € 14.324.956,00 € 0,082 € 1.173.808,00 Mercato AIM
2017 12.371.530 € 1,00 € 12.371.530,00 € 0,081 € 1.001.266,00 Mercato AIM
2016 11.245.580 € 1,00 € 11.245.580,00 0,00€ 0,00€ Unlisted
Shareholding
Health Italia S.p.A.’s share capital is 18.978.097,00 € (Euro) represented by 18.978.097 ordinary shares with a nominal value of 1 € each.

Shareholding Number of shares % Share of ordinary capital
Sorgiva Holding S.p.A. 4.739.080 24,97 %
Mutua MBA Società di Mutuo Soccorso SCpA 2.390.914 12,60 %
PFH S.r.l. 1.778.686 9,37 %
Amara Life Holdings Ltd 1.209.983 6,38 %
Own actions * 152.110 0,80 %
Market ** 8.707.324 45,88 %
* shares held by Health Italia directly and through its subsidiaries
** of which 11.93% of the share capital held by non-significant shareholders who signed the shareholders' agreement announced with a press release dated 8 April 2022, which is not a float.

Updated on 31.10.2023.

From 1th July 2019 Health Italia stocks are negotiable with a minimum units lot.

There is no record of other shareholders apart from those listed above owning a share in the capital exceeding 5% that have notified Consob and Health Italia S.p.A. pursuant to art. 117 of Consob Regulation no. 11971/99 concerning the notification obligations for the relevant holdings.

Health Italia has met the requirements for the qualification of issuer with financial instruments distributed between the public to a significant extent pursuant to art. 2-bis of Consob Regulation no. 11971 of 1999. This qualification is effective starting from the 2020 financial year.
Significant Shareholders
Pursuant to the Euronext Growth Milan Regulation, anyone who holds at least 5% of a category of financial instruments of Health Italia S.p.A. he is a "Significant Shareholder".
Exceeding the 5% threshold and reaching or exceeding the 5%, 10%, 15%, 20%, 25%, 30%, 50%, 66.6% and 90% or the reductions below these thresholds, constitute a "Substantial Change" which must be communicated by Significant Shareholders to the administrative body of Health Italia SpA.

To this end, within 4 trading days, starting from the day on which the transaction that led to the Substantial Change was carried out, the Significant Shareholder must communicate to Health Italia S.p.A .:

  • the identity of the Significant Shareholders involved;
  • the date on which Health Italia S.p.A. has been informed;
  • the date on which the Substantial Change of the investments took place;
  • the nature and extent of the participation of the Significant Shareholder in the transaction.

The communication can be made using the attached form, sent in advance via email to the address investor@healthitalia.it and subsequently sent in original with registered letter with return receipt to be sent to the administrative body at the company's registered office or via communication to the e-mail address certified by the company (healthitalia@legalmail.it).
Internal Dealing Communications

Internal Dealing Year 2022

Assembly
2019th Documents
Financial Reports
Below you can find the financial reports for the last two years:

Interim and periodic reports
Annual accounts
Financial Calendar
DATE EVENTS
March 6, 2023 Board of Directors - examination of the main preliminary consolidated results as at 31 December 2022
29 March 2023 Board of Directors - approval of the draft financial statements and consolidated financial statements as at 31 December 2022
3 April 2023 Health Italia at the “Spring Investor Conference” organized by Banca Profilo
April 28, 2023 Shareholders' meeting - approval of the financial statements and presentation of the consolidated financial statements as at 31 December 2022
May 18, 2023 Board of Directors - examination of additional periodic information as of March 31, 2023
June 8, 2023 Health Italia at the "Iberian Midcap Digital Event 2023" organized by Banca Profilo
June 13, 2023 Health Italia at the "Geneva Spring Midcap Event 2023" organized by Banca Profilo
July 13, 2023 Board of Directors - approval of the 2023-2026 Business Plan
September 14, 2023 Health Italia participates in the “Autumn Investor Conference” organized by Banca Profilo
September 21, 2023 Board of Directors - approval of the half-yearly report as of 30 June 2023
October 31, 2023 Health Italia at the "Frankfurt Autumn Midcap Event" organized by CF&B Communication
15/16 November 2023 Health Italia at the “Münchner Kapitalmarkt Konferenz” organized by GBC Ag
17 November 2023 Board of Directors - examination of additional periodic information as of 30 September 2023
Investor Relator

Admission document


You must read and accept the following information before accessing this section of the website. Consider carefully before reading, accessing, or otherwise using the information provided below. By accessing this section of the website, you agree to be subject to the terms and conditions below, which may or may not be modified or updated and should, therefore, be read in full upon each access to this site. The admission document contained in this section of the website ("Admission Document") is an Admission Document regarding Euronext Growth Milan, an alternative capital market multilateral trading facility organised and managed by Borsa Italiana SpA, of the ordinary shares of HEALTH ITALIA SpA and has been prepared in accordance with Euronext Growth Milan Issuers' Regulations. The Admission Document and the Transaction described in it do not constitute an offer to the public of financial instruments or admission of financial instruments in a regulated market as defined by Legislative Decree 24 February 1998, no. 58, Consob Regulation 14 May 1999, no. 11971 and the equivalent provisions of law and regulations applicable abroad. Access to this section of the Website, the Admission Document and any other information contained in the following pages is only permitted to individuals that:

  • are resident in Italy and who are not domiciled or in any case currently staying in the United States, Australia, Japan, Canada or any other country where the circulation of the Admission Document and/or of any such information that requires the approval of the local authorities or is in violation of local rules or regulations (“Other Countries”);
  • they are not a "U.S. Person" as defined in Regulation S of the United States Securities Act of 1933, as subsequently amended.

Any "U.S. Person" as defined in the aforementioned paragraph is precluded from any access to this section of the Website, temporary or permanent download and saving of the Admission Document or any other information contained in this section of the Website. The information contained in this section of the website cannot be copied or forwarded. For no reason and under no circumstances, are you allowed to circulate, directly or through third parties, the Admission Document and any other information contained in this section of the website outside of Italy, particularly in the United States, Australia, Japan, Canada or Other Countries, or distribute the Admission Document to non-resident Italian citizens.
Regulation S of the United States Securities Act of 1933, as subsequently amended, defines a "U.S. Person" as:

  1. any physical person residing in the United States;
  2. "partnerships" and "corporations" established and organized according to the law in force in the United States;
  3. any property whose administrators or managers are a "U.S. Person";
  4. trusts whose trustee is a "U.S. Person";
  5. any agency, branch or subsidiary of a subject having its headquarters in the United States;
  6. non-discretionary accounts;
  7. other similar accounts (except properties or trusts), managed or administered confidentially on behalf of or for the benefit of a "U.S. Person";
  8. "partnerships" and "corporations" if (i) set up and organised according to the laws of any foreign jurisdiction; and (ii) constituted by a "U.S. Person" with the principal aim of investing in unlisted securities under the United States Securities Act of 1933, as subsequently amended, unless they are constituted or organized and owned by accredited investors (as defined in Rule 501 (a) of United States Securities Act of 1933) that are not natural persons, properties or trusts

To access this section of the website, the Admission Document and any other information contained in the following pages, I declare under my sole responsibility that I am resident in Italy and not domiciled or presently staying in the United States, Australia, Japan, Canada or Other Countries and that I am not a "U.S. Person" as defined in Regulation S of the United States Securities Act of 1933, as subsequently amended.

I confirm I have read and agree to the above Terms and Conditions

Download the PDF file of the Admission Document

Keep in touch with us

Enter your email here to receive news from the world of Health Italia